CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated ...

All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...

Moderna announced on Friday that its updated COVID-19 mRNA vaccine, Spikevax, has received authorization in Canada for those ...

Shares in drug giant Moderna ($MRNA) were over 5% healthier today after Canada said yes to its Covid vaccine. Health Canada said it had given the ...

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...

The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read an analysis of MRNA stock now.

While Moderna is certainly enthusiastic about its near-term mRNA prospects, the company’s COVID-19 business is going through an odd patch, which has afflicted pandemic players of all stripes.

Moderna's motion to dismiss a patent infringement lawsuit centered on COVID-19 vaccine technology fell short after the company argued that the case should be directed at the U.S. government rather ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...